Page last updated: 2024-11-01

omeprazole and Blindness

omeprazole has been researched along with Blindness in 7 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.

Research Excerpts

ExcerptRelevanceReference
"During the following 2 weeks, amaurosis persisted on the left eye."2.48Blindness following severe midfacial trauma--case report and review. ( Hingst, V; Lenz, JH; Roth, J, 2012)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (85.71)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roth, J1
Hingst, V1
Lenz, JH1
Lessell, S1
Classen, M1
Blum, AL1
Creutzfeldt, W1
Labenz, J1
Stolte, M2
Günther, K1

Reviews

1 review available for omeprazole and Blindness

ArticleYear
Blindness following severe midfacial trauma--case report and review.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2012, Volume: 40, Issue:7

    Topics: Anti-Inflammatory Agents; Anti-Ulcer Agents; Blindness; Dexamethasone; Facial Bones; Glucocorticoids

2012

Other Studies

6 other studies available for omeprazole and Blindness

ArticleYear
[Federal health office commentaries: false, misleading citations].
    Leber, Magen, Darm, 1995, Volume: 25, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Anti-Ulcer Agents; Blindness; Germany; Humans; Omeprazole;

1995
[Who is affected by blindness?].
    Leber, Magen, Darm, 1995, Volume: 25, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Anti-Ulcer Agents; Blindness; Deafness; Drug Approval; Huma

1995
[We hope that the responsible persons learn from the experience!].
    Leber, Magen, Darm, 1995, Volume: 25, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Anti-Ulcer Agents; Blindness; Deafness; Drug Approval; Germ

1995
[Vision and hearing disorders with omeprazole: the facts].
    Leber, Magen, Darm, 1995, Volume: 25, Issue:1

    Topics: Blindness; Deafness; Gastrointestinal Diseases; Germany; Humans; Omeprazole; Product Surveillance, P

1995
["A defective public health office monitors health"].
    Leber, Magen, Darm, 1995, Volume: 25, Issue:1

    Topics: Blindness; Drug Approval; Germany; Humans; Infusions, Intravenous; Omeprazole; Product Surveillance,

1995
["A sick public health services watches over health status": how the former Federal Public Health Office turned German medicine exemplified by "omeprazole and blindness" into an international joke].
    Leber, Magen, Darm, 1994, Volume: 24, Issue:5

    Topics: Blindness; Deafness; Drug Approval; Germany; Humans; Omeprazole; Quality Assurance, Health Care

1994
chemdatabank.com